A Bright Opportunity for Growth
Introducing OptiLight™ by Lumenis Vision, the first and only light therapy for dry eye management.
Powered by Optimal Pulse Technology™, it provides safe, targeted, and effective treatment backed by
over 50 clinical studies. Dry eye disease affects millions, with Meibomian Gland Dysfunction (MGD)
responsible for 86% of cases.
Lumenis' FDA-approved trial showed significant improvements in tear breakup time, meibum quality, and gland function. This quick, in-office treatment offers real results for your patients while helping you scale your practice.
Dr. Douglas K. Devries says, “Without OptiLight, you’re not offering everything for your patients.”
Elevate your practice and join our upcoming webinar with Corporate Optometry featuring Dr. James Deom to explore how OptiLight can enhance your dry eye care.
Lumenis' FDA-approved trial showed significant improvements in tear breakup time, meibum quality, and gland function. This quick, in-office treatment offers real results for your patients while helping you scale your practice.
Dr. Douglas K. Devries says, “Without OptiLight, you’re not offering everything for your patients.”
Elevate your practice and join our upcoming webinar with Corporate Optometry featuring Dr. James Deom to explore how OptiLight can enhance your dry eye care.
